Suppr超能文献

结缔组织病相关性肺动脉高压:新证据与新挑战。

Pulmonary hypertension in connective tissue diseases, new evidence and challenges.

机构信息

Department of the Rheumatic diseases, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.

Department of Cardiology, Gent University, Gent, Belgium.

出版信息

Eur J Clin Invest. 2021 Apr;51(4):e13453. doi: 10.1111/eci.13453. Epub 2020 Dec 5.

Abstract

Pulmonary arterial hypertension is a lethal complication of different connective tissue diseases such as systemic sclerosis, mixed connective tissue disease and systemic lupus erythematosus. Although the treatment possibilities for patients with pulmonary arterial hypertension have increased in the last two decades and survival of patients with idiopathic pulmonary arterial hypertension has improved, the latter is not the case for patients with pulmonary arterial hypertension associated with connective tissue disease. In this narrative review, we review recent literature and describe the improvement of early diagnostic possibilities, screening modalities and treatment options. We also point out the pitfalls in diagnosis in this patient category and describe the unmet needs and what the focus of future research should be.

摘要

肺动脉高压是系统性硬皮病、混合性结缔组织病和系统性红斑狼疮等多种结缔组织疾病的致命并发症。尽管在过去二十年中,肺动脉高压患者的治疗选择有所增加,特发性肺动脉高压患者的生存率也有所提高,但与结缔组织病相关的肺动脉高压患者并非如此。在这篇叙述性综述中,我们回顾了最近的文献,并描述了早期诊断可能性、筛查方法和治疗选择的改进。我们还指出了在这一患者群体中诊断的缺陷,并描述了未满足的需求以及未来研究的重点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6592/7988614/b40194943882/ECI-51-e13453-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验